Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S24 pseudogene 19 (RPS24P19) is classified as a pseudogene, specifically a non-functional DNA segment related to the ribosomal protein S24 gene. Pseudogenes like RPS24P19 arise through duplication or retrotransposition events and typically do not yield functional proteins. While the parent gene (RPS24) encodes a component of the small ribosomal 40S subunit involved in protein synthesis, the RPS24P19 pseudogene itself is not transcribed into a functional protein and has no documented biological or clinical relevance. It is not considered a therapeutic target, does not play a known role in human disease, and has no known interacting drugs or safety concerns[2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S24 pseudogene 19 (RPS24P19).